Rxo Inc (NYSE:RXO – Get Free Report)’s share price reached a new 52-week high during trading on Friday . The company traded as high as $18.84 and last traded at $18.8910, with a volume of 115746 shares. The stock had previously closed at $17.98.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the company. Stephens set a $15.00 price target on RXO in a report on Monday, February 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of RXO in a research report on Monday, December 22nd. Barclays upped their target price on shares of RXO from $15.00 to $17.00 and gave the company an “overweight” rating in a research note on Wednesday, March 4th. Citigroup raised their price target on shares of RXO from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 9th. Finally, Susquehanna lifted their price target on shares of RXO from $10.00 to $11.00 and gave the stock a “negative” rating in a research note on Thursday, January 8th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $15.77.
Read Our Latest Analysis on RXO
RXO Price Performance
RXO (NYSE:RXO – Get Free Report) last released its quarterly earnings results on Friday, February 6th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.03). RXO had a negative return on equity of 0.44% and a negative net margin of 1.74%.The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the business posted $0.06 earnings per share. The firm’s revenue was down 11.9% on a year-over-year basis. Analysts predict that Rxo Inc will post 0.31 EPS for the current fiscal year.
Hedge Funds Weigh In On RXO
Institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Financial Group Inc. grew its stake in shares of RXO by 11.8% during the 3rd quarter. Principal Financial Group Inc. now owns 791,799 shares of the company’s stock valued at $12,178,000 after acquiring an additional 83,305 shares during the period. Finepoint Capital LP bought a new stake in RXO during the 3rd quarter valued at approximately $111,764,000. Cornerstone Wealth Group LLC bought a new stake in shares of RXO during the third quarter valued at approximately $4,026,000. Public Sector Pension Investment Board increased its holdings in RXO by 31.6% in the 3rd quarter. Public Sector Pension Investment Board now owns 639,606 shares of the company’s stock valued at $9,837,000 after acquiring an additional 153,468 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of RXO by 1.4% during the 3rd quarter. Vanguard Group Inc. now owns 17,216,681 shares of the company’s stock valued at $264,793,000 after purchasing an additional 233,434 shares during the last quarter. 92.73% of the stock is currently owned by hedge funds and other institutional investors.
RXO Company Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Further Reading
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
